Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2003
08/21/2003US20030158099 Cancer therapy
08/21/2003US20030158093 For therapy of bacterial infections
08/21/2003US20030158087 Novel use of fulmonary surfactant for the prophylaxis or early treatment if acute fulmonary diseases
08/21/2003US20030157704 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
08/21/2003US20030157703 Recombinant herpesvirus of turkeys and use thereof
08/21/2003US20030157692 Papillomavirus infected epithelial cells and methods of producing infectious papillomavirus in epithelial cells and uses thereof
08/21/2003US20030157160 Vaccine for modulating between T1 and T2 immune responses
08/21/2003US20030157138 Pharmaceutical or cosmetic carrier or composition for topical application onto skin and/or mucosal membranes; treatment of skin diseases or disorders including eczema, psoriasis and dermatitis
08/21/2003US20030157135 Enhancement and/or extension of antigen-specific Th1-type responses, in particular, CD8+ T cell responses; for treatment of various infectious and neoplastic diseases
08/21/2003US20030157133 For treating, preventing, or inhibiting an infection or disease caused by a gram-positive organism including Streptococcus, Micrococcus, Lactobacillus, Staphylococcus, Bacillus, or Listeria
08/21/2003US20030157132 Remedies for hepatitis c
08/21/2003US20030157131 Interferon inducing genetically engineered attenuated viruses
08/21/2003US20030157124 Chlamydia membrane ATPase and corresponding DNA molecules, which can be used to prevent and treat Chlamydia infection in mammals such as humans
08/21/2003US20030157108 80-100% of the glycoprotein has a mature core carbohydrate structure which lacks fucose, attached to a Fc region
08/21/2003US20030157094 Prevention, therapy liver disorders, inflammatory bowel diseases, Crohn's disease; antiulcer agents; rheumatic diseases
08/21/2003US20030157090 Redox systems; accumulation of polypeptide in plant cell; genetic engineering
08/21/2003US20030157079 Adhesion to mucous membranes; cell proliferation; prevention, therapy of digestion diseases
08/21/2003CA2482333A1 Human antibodies for therapy against vaccinia or smallpox
08/21/2003CA2476618A1 Phenalenone derivatives, method for the production thereof and use of the same
08/21/2003CA2476556A1 Modulation of immune response by non-peptide binding stress response polypeptides
08/21/2003CA2476530A1 Methods for producing interfering rna molecules in mammalian cells and therapeutic uses for such molecules
08/21/2003CA2476282A1 Dosing regimen for gemcitabine hcv therapy
08/21/2003CA2476279A1 Modified fluorinated nucleoside analogues
08/21/2003CA2476223A1 Macrolide antibacterial compounds
08/21/2003CA2475770A1 Microglia inhibitors for interrupting immune reactions induced by interleukin 12 and ifn.gamma.g(g)
08/21/2003CA2475708A1 Nicotinamide derivatives useful as pde4 inhibitors
08/21/2003CA2475703A1 Aryl ureas with angiogenesis inhibiting activity
08/21/2003CA2475544A1 Oral dosage form for controlled drug release
08/21/2003CA2475522A1 Method of radio-labelling biomolecules
08/21/2003CA2475439A1 Novel pyridazine derivatives, use of the same as medicaments, pharmaceutical compositions and method for producing the same
08/21/2003CA2475102A1 Stabilized synthetic immunogen delivery systems
08/21/2003CA2474782A1 Antibody having a t-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
08/21/2003CA2474405A1 Medicament for the treatment of choroidal neovascularisation
08/21/2003CA2474017A1 Novel anti-fungal agents
08/21/2003CA2472822A1 Chemical compounds
08/21/2003CA2472603A1 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
08/21/2003CA2452854A1 Identification of actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases
08/20/2003EP1336621A2 Immune responses against HPV antigens elicited by compositions comprising an HPV antigen and a stress protein or an expression vector capable of expression of these proteins
08/20/2003EP1336620A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding
08/20/2003EP1336612A1 Novel carbapenem derivatives
08/20/2003EP1336600A2 Dimer-selective RXR modulators and methods for their use
08/20/2003EP1335935A1 Periplasmic domain of an enterobacterium omp protein and its use as carrier or adjuvant
08/20/2003EP1335933A2 Pna analogues
08/20/2003EP1335924A2 Ethers of 7-desmethylrapamycin for use in immunosuppression
08/20/2003EP1335898A1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
08/20/2003EP1335895A2 Protease inhibitors and their pharmaceutical uses
08/20/2003EP1335748A1 Antibiotic adducts with natural polysaccharide polymers in the form of aqueous solutions
08/20/2003EP1335738A2 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants
08/20/2003EP1335734A1 Method for treating hiv
08/20/2003EP1335693A2 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
08/20/2003EP1212327B1 Pyrazolopyrimidines as therapeutic agents
08/20/2003EP1212326A4 PYRROLO 2,3-d]PYRIMIDINE NUCLEOSIDE ANALOGS
08/20/2003EP1165566B1 Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/20/2003EP1146892B1 Baff, inhibitors thereof and their use in the modulation of the b-cell response
08/20/2003EP1086106B1 Furopyridine derivatives and their therapeutical use
08/20/2003EP1053233B1 Hydroxamic and carboxylic acid derivatives
08/20/2003EP1017727B1 Composition and pharmaceutical preparation containing same for the treatment of herpes and related viral infections
08/20/2003EP0900083B1 Novel substituted imidazole compounds
08/20/2003EP0861091B1 Immunotoxin containing a disulfide-stabilized antibody fragment
08/20/2003EP0817852B1 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
08/20/2003EP0693938B1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus
08/20/2003CN1437655A Assembly of wild-type and chimeric influenza virus-like particles (VLPS)
08/20/2003CN1437653A Antigenic polypeptides
08/20/2003CN1437652A Compounds and methods for treatment and diagnosis of chlamydial infection
08/20/2003CN1437611A 糖肽膦酸盐衍生物 Glycopeptide phosphonate derivatives
08/20/2003CN1437609A Method used for transforming the carbonyl function in position 4´“éof a cladinose unit of an aza macrolide into an amine derivative
08/20/2003CN1437606A Novel cephalosporin compounds and process for preparing the same
08/20/2003CN1437603A Oxazolidinone derivatives with antibiotic activity
08/20/2003CN1437600A Pyrroloquinolones as antiviral agents
08/20/2003CN1437599A Tryasolyl tropane derivatives for therapy
08/20/2003CN1437588A Inhibitors of 11-beta-hydroxy steroid dehydrogenase type l
08/20/2003CN1437584A Tricyclic protein kinase inhibitors
08/20/2003CN1437484A New formulation comprising a beta-blocker and optionally a cholesterol-lowering agent
08/20/2003CN1437480A Compositions and methods for treatment of mucosal infections
08/20/2003CN1437479A Recombinant intracellular pathogen vaccines and methods for use
08/20/2003CN1437468A Halogentated 2-amino-5.6-heptenoic aicd derivatives useful as nitric oxide synthase inhibitors
08/20/2003CN1437467A Medium chain fatty acids applicable as anitmicrobial agents
08/20/2003CN1437466A Methods for pulmonary delivery of interleukin-2
08/20/2003CN1437463A System and method for treating a mucosal surface
08/20/2003CN1437462A Effervescence particles and preparing method thereof
08/20/2003CN1436570A Production process and application of improved human alpha-interferon
08/20/2003CN1436569A Medicine for treating children's cold and its prepn process
08/20/2003CN1436562A Hypericum perforatum extract and its prepn process and medicine composition
08/20/2003CN1436557A Disinfectant
08/20/2003CN1436554A Bupleurum-skullcap dripping pills
08/20/2003CN1436552A Parotitis treating medicine
08/20/2003CN1436530A Rationed fenmameimin drops
08/20/2003CN1118573C Non-splicing variants of gp 350/220
08/20/2003CN1118476C Antiviral protease inhibitors
08/20/2003CN1118475C Cyclopeptide derivatives
08/20/2003CN1118474C Synthetic peptides and vaccines containing the same
08/20/2003CN1118473C Aqueous soluble steroid compound alkaloid salt, producing process and medicinal composition containing same
08/20/2003CN1118471C Process for preparing tan matter caesalpinia
08/20/2003CN1118469C Preparation of and/or purifing method for clavate acid or salt or ester acceptable in pharmacy
08/20/2003CN1118299C Gonococcal anti-idiotypic antibodies and using methods and composition thereof
08/20/2003CN1118284C Medicinal composition for treating beriberi and preparing process thereof
08/20/2003CN1118281C New use of seeweed polyose sulphate
08/20/2003CN1118278C Application of ursolic acid in medicine for treating viral hepatitis
08/19/2003US6608192 Collections of compounds
08/19/2003US6608191 Antisense oligonucleotide of given sequence; capable of inhibiting the function of viral RNA
1 ... 1156 1157 1158 1159 1160 1161 1162 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 ... 1798